Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
16.93
0.07 (0.42%)
At close: Aug 15, 2025, 3:59 PM
16.95
0.12%
After-hours: Aug 15, 2025, 07:36 PM EDT
Spyre Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -206.81M | -208.93M | -208.02M | -214.9M | -185.98M | -364.23M | -338.79M | -294.43M | -272.56M | -77.8M | -83.81M | -85.44M | -87.51M | -72.02M | -65.8M | -68.07M | -65.8M | -80.38M |
Depreciation & Amortization | n/a | n/a | n/a | -220K | -220K | 360K | 744K | 1.45M | 1.96M | 1.85M | 1.96M | 1.98M | 2M | 2.04M | 1.89M | 1.76M | 1.48M | 1.2M |
Stock-Based Compensation | 40.55M | 39.86M | 44.83M | 52.89M | 44.57M | 37.8M | 25.68M | 8.4M | 3.62M | 1.71M | n/a | n/a | n/a | n/a | 1.76M | 3.37M | 5.07M | 6.67M |
Other Working Capital | 51.44M | 15.65M | 27.01M | -5.35M | -36.01M | 5.09M | -5.42M | -2.44M | 3.38M | -1.98M | -3.3M | -8.17M | -6.26M | -21.64M | 768K | 7.24M | 6.76M | 21.19M |
Other Non-Cash Items | -23.83M | -5.49M | 15.16M | 34.74M | 42.59M | 43.32M | 27.34M | 14.51M | 6.16M | 10.53M | 13.78M | 9.69M | 13.04M | 11.54M | 8.24M | 6.6M | 2.98M | 398K |
Deferred Income Tax | n/a | n/a | n/a | -1.71M | -1.71M | 190.43M | 190.32M | 192.03M | 192.03M | -107K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 35.91M | 6.76M | 10.8M | -1.86M | -35.5M | -369K | -5.21M | -4.5M | 4.58M | -2.46M | -5.5M | -5.86M | -6.49M | 963K | 1.83M | 6.84M | 4.85M | -1.49M |
Operating Cash Flow | -154.18M | -169.86M | -157.41M | -151.25M | -156.42M | -110.82M | -99.91M | -87.01M | -67.48M | -71.52M | -80.14M | -81.27M | -83.2M | -60.45M | -53.72M | -51.58M | -52.12M | -73.61M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -1K | -38K | -38K | -130K | -160K | -573K | -1.57M | -2.05M | -3.34M |
Cash Acquisitions | n/a | n/a | n/a | -15.47M | -475K | n/a | n/a | 15.47M | 475K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -374.46M | -517.98M | -599.25M | -420.33M | -497.91M | -319.52M | -166.8M | -117.13M | -11.75M | -36M | -39.5M | -48.25M | -67.25M | -112.33M | -133.08M | -150.83M | -147.08M | -149.25M |
Sales Maturities Of Investments | 318.59M | 269.6M | 245.97M | 202.32M | 124.53M | 69.9M | 39.9M | 39.5M | 63.25M | 85M | 96.55M | 100.96M | 109.33M | 106.33M | 111.03M | 148.74M | 145.47M | 139.53M |
Other Investing Acitivies | 7M | n/a | n/a | 15.47M | 15.47M | 18.51M | 18.51M | 3.04M | 3.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -48.87M | -248.38M | -353.29M | -218.01M | -358.38M | -231.11M | -108.39M | -59.12M | 55.01M | 49M | 57.01M | 52.67M | 41.95M | -6.16M | -22.62M | -3.66M | -3.65M | -13.06M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | -8K | -16K | -24K | -87K | -254K | -418K | -579K | -624K | -677K | -510K | -347K | -245K | -18K |
Common Stock Repurchased | -117K | -117K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.77M | 170.6M | 173.44M | 167.98M | 166.74M | -2.83M | -5.77M | 18K | 18K | 43M | 43.16M | 43.41M | 44.66M | 1.68M | 1.87M | 1.69M | 850K | 894K |
Financial Cash Flow | 239.24M | 238.87M | 410.91M | 348.91M | 323.6M | 533.23M | 361.08M | 197.46M | 209.86M | 42.68M | 42.68M | 42.77M | 44.04M | 1.04M | 1.39M | 25.99M | 25.11M | 154.59M |
Net Cash Flow | 36.52M | -179.06M | -99.47M | -20M | -191.21M | 191.32M | 152.8M | 51.36M | 197.65M | 20.36M | 19.72M | 14.32M | 2.73M | -65.58M | -74.93M | -29.2M | -30.61M | 67.98M |
Free Cash Flow | -154.18M | -169.86M | -157.41M | -151.25M | -156.42M | -110.82M | -99.91M | -87.01M | -67.49M | -71.52M | -80.18M | -81.31M | -83.33M | -60.61M | -54.29M | -53.15M | -54.16M | -76.95M |